The supportive effects of erythropoietin and mast cell growth factor on CD34+/CD36- sorted bone marrow cells of myelodysplasia patients

Blood

Volumn 88, Issue 2, 1996, Pages 505-510

  Brada, Simo ^a   De Wolf, Joost ^a   Hendriks, Dick ^a   Esselink, Mariet ^a   Ruiters, Marcel ^a   Vellenga, Edo ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD36 ANTIGEN; ERYTHROPOIETIN; INTERLEUKIN 3;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; BURST FORMING UNIT; CELL DIFFERENTIATION; CELL SORTER; CELL SUBPOPULATION; COLONY FORMING UNIT S; FLOW CYTOMETRY; GENE DISRUPTION; HUMAN; HUMAN CELL; MYELODYSPLASIA; PRIORITY JOURNAL; STEM CELL;

EID: 0029955622     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.2.505.bloodjournal882505     Document Type: Article

References (16)

1. French-American-British (FAB) Cooperative Group: Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 103:620, 1985
2. Backs B, Breoders L, Löwenberg B: Kit ligand in vitro erythropoiesis in myelodysplastic syndrome. Blood 80:1213, 1992
3. Merchav S, Wagemaker G, Souza LM, Tatarsky I: Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haematopoietic growth factors. Leukemia 5:340, 1991
4. Merchav S, Nielsen OJ, Rosenbaum H, Sharon R, Brenner B, Tatarsky I, Scigalla P, Wieczorek L: In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes. Leukemia 4:771, 1990
5. Backs B, Breoders L, Touw I, Löwenberg B: Blast colony-forming cells in myelodysplastic syndrome: Decreased potential to generate erythroid precursors. Leukemia 7:75, 1993
6. Russell M, List A, Woodward S, Glinsmann B, Parganas E, Ihle J, Taetle R: Expression of Evi-1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Blood 84:1243, 1994
7. Fichelson S, Dreyfus F, Berger R, Melle J, Bastard C, Miclea JM, Gisselbrecht S: Evi-1 expression in leukemic patients with rearrangements of the 3Q25-Q28 chromosomal region. Leukemia 6:93, 1992
8. Kreider BL, Orkin SH, Ihle JN: Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene. Proc Natl Acad Sci USA 90:6454, 1993
9. de Wolf JThM, Muller EW, Hendriks DW, Halie RM, Vellenga E: Mast cell growth factor modulates CD36 antigen expression on erythroid progenitors from human bone marrow and peripheral blood associated with ongoing differentiation. Blood 84:59, 1994
10. Muller EW, de Wolf JThM, Hen driks DW, Halie MR, Vellenga E: Mast cell growth factor supports erythroid colony formation in polycythemia vera in the presence and absence of serum and erytropoietin. Exp Hematol 21:1353, 1993
11. Morishata K, Parqanas E, Douglass E, Ihle JN: Unique expression of the human Evi-gene in an endometrial carcinoma cell line: Sequences of cDNAs and structure of alternatively spliced transcripts. Oncogene 5:963, 1990
12. Morishita K, Parganas E, Willman CL, Whittaker, Drabkin H, Oval J, Taetle R, Valentine MB, Ihle JN: Activation of Evi-1 gene expression in human acute myelogenous leukemias by translocation spanning 300-400 kilobases on chromosome band 3q26. Proc Natl Acad Sci USA 89:3937, 1992
13. Dreyfus F, Bouscary D, Melle J, Ribrag V, Guesnu M, Varet B: Expression of the Evi-1 gen in myelodysplastic syndromes. Leukemia 9:203, 1995
14. Melotti P, Calabretta B: Ets-2 and c-myb act independently in regulating expression of the hematopoietic stem cell antigen CD34. J Biol Chem 269:25303, 1991
15. Cuddihy AE, Brents LA, Aziz N, Bender TP, Kuehl WM: Only the DNA binding and transactivation domains of c-Myb are required to block terminal differentiation of murine erythroleukemia cells. Mol Cell Biol 13:3505, 1993
16. Fackler MJ, Smith OM, Krause DS, May WS: Constitutive expression of full-length, but not truncated, murine CD34 blocks terminal differentiation of myeloid cells. Exp Hematol 22:790, 1994 (abstr)